Searchable abstracts of presentations at key conferences in endocrinology

ea0025p37 | Clinical biochemistry | SFEBES2011

Polycythaemia in men treated with transdermal and intramuscular testosterone

Agustsson Tomas , McGowan Barbara , Powrie Jake , Thomas Stephen , Carroll Paul

Background: Testosterone replacement therapy has been shown to produce a wide range of benefits for men with hypogonadism with studies showing improvement in libido, bone density, muscle mass, body composition, mood, cognition, and erythopoiesis. The risks associated with testosterone replacement therapy are less well characterised and there is a lack of larger randomised trials. One recognised risk is polycythaemia. The aim of this study is to assess the frequency of polycyth...

ea0025p112 | Cytokines, growth factors, neuroendocrinology and behaviour | SFEBES2011

Characterisation of the stress--response in BACE1 heterozygous mice

Meakin Paul , Winter Johnathan , Ashford Mike , McNeilly Alison

Alzheimer’s disease (AD) is one of the most common causes of dementia world wide. Accumulation of β-amyloid (Aβ) has been implicated as a causal factor of AD. Beta secretase (BACE1) catalyses the rate limiting step in the production Aβ and has been postulated as a potential therapeutic target for AD treatment. Environmental factors, including psychological stress, accelerate the development of dementia and AD. This study examined hypothalamic–pituitary...

ea0025p206 | Growth and development | SFEBES2011

Effects of the prenatal environment on haematological and skeletal muscle parameters in one-week-old piglets: a role for glucocorticoids?

Fainberg Hernan , Almond Kayleigh , Bikker Paul , Symonds Michael , Mostyn Alison

Changes in maternal dietary intake during gestation can affect muscle development1 and may be linked to the catabolic actions of hormones, such as glucocorticoids, which inhibits the insulin like growth factor 1 (IGF1) pathway. This study examines the potential effects of glucocorticoids and skeletal muscle adaptations in seven-day-old offspring exposed to suboptimal gestational environments.Pregnant sows were randomly assigned to a commercial...

ea0025p233 | Pituitary | SFEBES2011

An unusual case of extremely high prolactin due to stalk disconnection hyperprolactinaemia

Haniff Haliza , Marks Paul V , Ismail Azzam , Moisey Robert S

A 75-year-old man was admitted acutely with a 1 week history of headaches, reduced visual acuity, diplopia and ptosis of his left eye. Examination confirmed a left III and VI nerve palsies with decreased visual acuity in the left eye. A CT and subsequent MRI revealed pituitary mass lesion measuring 2.4×2.1×1.5 cm with extension into the left cavernous sinus. The pituitary stalk appeared thickened and was deviated to the right. The optic apparatus was uninvolved.<...

ea0025p311 | Steroids | SFEBES2011

Hepatic 11β-hydroxysteroid dehydrogenase type 1 expression is dynamically related across the liver lobule and is linked to metabolic status

Ahmed Adeeba , Semjonous Nina , Rabbitt Elizabeth , Stewart Paul

Nearly all the functions of the liver display zonation in distribution within each the lobule. Hepatic cortisol availability is controlled by enzymes that regenerate cortisol from inactive cortisone (11β-hydroxysteroid dehydrogenase type 1, 11β-HSD1). Dysregulation of hepatic 11β-HSD1 activity has been implicated in insulin resistance. Key processes such as gluconeogenesis are located in the periportal hepatocytes, although current dogma describes hepatic 11&#94...

ea0025p343 | Thyroid | SFEBES2011

Optimal use of thyroid antibody assays in the identification of auto-immune thyroid disease

Kariyawasam Dulmini , Chuah Lingling , Granville Swana , Karim Yousuf , Carroll Paul

Background: A variety of thyroid antibody assays are used in the diagnosis of auto-immune thyroid disease (AITD). Commonly both thyroid peroxidase (TPOab) and thyroglobulin antibodies (TGab) are measured but the added value of testing two markers has not been established.Method: We retrospectively collected clinical and laboratory data on 500 consecutive patients who had thyroid autoantibodies requested from a specialist endocrine department of a tertiar...

ea0024p35 | (1) | BSPED2010

NAFLD in type 1 DM: a report of 2 cases

Kumar P , Ghatak A , Blair J C , Didi M , Paul P

Introduction: Non-alcoholic steatohepatitis (NASH) is part of the spectrum of non-alcoholic fatty liver disease (NAFLD). NASH commonly occurs in patients with type 2 DM and is less recognised in type 1 DM. The natural history of NASH in adult patients suggests potential development of progressive fibrosis and cirrhosis. However, secondary glycogenosis, commonly occurs in type 1 DM, is reversible when good glycaemic control is achieved, but may be misidentified as NASH b...

ea0021p180 | Diabetes and metabolism | SFEBES2009

Impact of glucocorticoids upon lipogenesis and β-oxidation in skeletal muscle

Morgan Stuart , Gathercole Laura , Stewart Paul , Smith Dave , Tomlinson Jeremy

Glucocorticoid excess is characterized by increased adiposity, skeletal myopathy and insulin resistance. Although there is a strong inverse correlation between intramuscular triglyceride (IMTG) levels and insulin sensitivity, the impact of glucocorticoids upon the processes that regulate skeletal muscle lipid metabolism has not been explored.Mouse C2C12 skeletal myocytes were grown to confluence and differentiated into myotubes in chemically defined medi...

ea0021p222 | Endocrine tumours and neoplasia | SFEBES2009

Parafibromin, a tumour suppressor protein, interacts with transforming acidic-coiled coil protein 3 and kinesin family member 5B

Newey Paul , Bowl Michael , Gergely Fanni , Thakker Rajesh

Parafibromin is a tumour suppressor protein, encoded by the gene responsible for the hyperparathyroidism-jaw tumour (HPT-JT) syndrome, which is an autosomal dominant disorder, characterised by parathyroid tumours, ossifyfing fibromas, renal and uterine tumours. Parafibromin is a component of the polymerase-associated factor 1 (PAF1) complex and interacts directly with β-catenin, although these functions do not fully explain its role in tumourigenesis. To further investiga...

ea0021p225.1 | Endocrine tumours and neoplasia | SFEBES2009

The microRNA let-7a is downregulated in pituitary tumours from a multiple endocrine neoplasia type-1 mouse model

Dyar Rebecca , Newey Paul , Nesbit Andrew , Walls Gerard , Thakker Rajesh

MicroRNAs are highly conserved non-coding RNAs that regulate diverse cellular processes. Altered microRNA expression is observed in many human cancers and microRNAs may have tumour suppressor or oncogenic properties. One group of putative tumour suppressor microRNAs is the let-7 family whose expression is reduced in several human tumours, and which inhibit the expression of several oncogenes including HMGA2 and K-Ras. Let-7 expression have also been observed to b...